Perimenopausal insomnia
Conditions
Interventions
Western medicine group:Dexzopiclone + oryzanol
Wuyin treatment group:Dexzopiclone + oryzanol+Wuyin therapy
Bushen Anshen Decoction group:Dexzopiclone + oryzanol+Bushen Anshen Decoction
Combined treatment group:Dexzopiclone + oryzanol+Bushen Anshen Decoction+Wuyin therapy
Sponsors
Chen Pei
Eligibility
Sex/Gender
Female
Age
45 Years to 55 Years
Inclusion criteria
Inclusion criteria: (1) Aged between 45 and 55 years old in the perimenopausal period; (2) Western medicine diagnosis: according to the international classification of sleep disorders it meets the relevant standards of insomnia (such as difficulty in falling asleep difficulty in maintaining sleep early awakening etc.); (3) The dialectical classification is kidney deficiency and liver depression; (4) No history of major diseases (such as serious heart disease liver and kidney dysfunction etc.) affecting treatment or sleep; (5) Voluntary participation in the study participants need to have treatment compliance voluntarily participate in the study and comply with the study protocol including regular follow-up and receiving treatment intervention; (6) And signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) There are serious organic diseases (such as cardiovascular disease liver and kidney dysfunction etc.); (2) Have a history of mental illness or are receiving psychotherapy; (3) Previous ovariectomy hysterectomy or surgical treatment of uterus ovary and breast; (4) Pregnant or lactating women; (5) Taking other drugs that affect sleep such as sleeping pills.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSQI; | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-36;neurotransmitter;HAMA;sex hormone;HAMD; | — |
Countries
China
Contacts
Public ContactChen Pei
Xi'an Fifth Hospital
Outcome results
None listed